EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases

Ugnė Šinkevičiūtė iD, Kateřina Burgetová Ječmeňová iD, Soňa Gurská iD, Lenka Poštová Slavětínská, Vincent Baran, Pavel Polishchuk iD, Petr Džubák iD, Michal Hocek iD, Marián Hajdúch, Michal Tichý iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Ugnė Šinkevičiūtė und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6, Czech Republic. Hauptthemen laut MEDLINE: Purines, Antineoplastic Agents, Purinergic P1 Receptor Antagonists. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Školství, Mládeže a Tělovýchovy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐throughput screening of the IMTM compound library for modulatory activity on adenosine receptors (ARs) identified two deazapurine hits based on 2,6‐diaryl‐7‐deazapurines. In this study, a series of 16 new 2,6‐diaryl‐7‐deazapurine nucleobases together with four N‐9 substituted derivatives were synthesized. The synthesis was based on regioselective Suzuki cross‐coupling into position 6 followed by a second Suzuki cross‐coupling at position 2 under harsher conditions. Both cross‐couplings were performed on N‐9 protected nucleobases. Biological activity profiling identified several potent antagonists of all four subtypes of ARs and four compounds as sub‐micromolar and very selective antagonists of A 3 . Several final compounds showed potent in vitro cytotoxic activity on a small panel of cancer cell lines, but with no selectivity against nonmalignant fibroblasts BJ and MRC‐5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PurinesAntineoplastic AgentsPurinergic P1 Receptor AntagonistsHumansStructure-Activity RelationshipCell Line, TumorMolecular StructureReceptors, Purinergic P1Dose-Response Relationship, DrugDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

7‐deazapurineSuzuki cross‐couplingadenosine receptor antagonist

Substanzen

Purines7-deazapurineAntineoplastic AgentsReceptors, Purinergic P1Purinergic P1 Receptor Antagonists

Autor:innen und Institutionen

  • Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6, Czech Republic.
  • Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Prague 2, Czech Republic.
  • Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic.

ORCID-Profile: Ugnė Šinkevičiūtė, Kateřina Burgetová Ječmeňová, Soňa Gurská, Pavel Polishchuk, Petr Džubák, Michal Hocek, Michal Tichý

Förderung

  • Ministerstvo Školství, Mládeže a Tělovýchovy

Zitieren

APA

Šinkevičiūtė, U., Burgetová Ječmeňová, K., Gurská, S., Poštová Slavětínská, L., Baran, V., Polishchuk, P., Džubák, P., Hocek, M., Hajdúch, M., & Tichý, M. (2026). Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases. ChemMedChem. https://doi.org/10.1002/cmdc.70419

Vancouver

Šinkevičiūtė U, Burgetová Ječmeňová K, Gurská S, Poštová Slavětínská L, Baran V, Polishchuk P, et al. Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases. ChemMedChem. 2026. doi:10.1002/cmdc.70419

BibTeX
@article{inkeviit2026,
  author = {Šinkevičiūtė, Ugnė and Burgetová Ječmeňová, Kateřina and Gurská, Soňa and Poštová Slavětínská, Lenka and Baran, Vincent and Polishchuk, Pavel and Džubák, Petr and Hocek, Michal and Hajdúch, Marián and Tichý, Michal},
  title = {Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70419}
}
Kostenlos starten →